Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Slides:

Advertisements

Similar presentations

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Advertisements

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Elizabeth A. David, MD, David T

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Thomas J. Birdas, MD, Richard P. M

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival Elizabeth A. David, MD, Robert J. Canter,

Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,

Chun Chieh Lin, PhD, MBA, Matthew P

Joshua E. Rosen, BASc, Hari B

Ravi Rajaram, MD, MSc, Jennifer L

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer Lars P. Riber, MD, PhD, Thomas D. Christensen,

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Andrea S. Wolf, MD, MPH, Scott J

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Lung Cancer Surgery in Patients With Liver Cirrhosis

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Lung Cancer and Its Operable Brain Metastasis: Survival Rate and Staging Problems József Furák, MD, PhD, Imre Troján, MD, Tamás Szöke, MD, László Agócs,

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic.

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy

Long-Term Follow-Up of Ultraflex Metallic Stents in Benign and Malignant Central Airway Obstruction Syed A. Husain, MRCP, David Finch, BS (Hons), Manzoor.

Bronchoscopic Management of Patients With Symptomatic Airway Stenosis and Prognostic Factors for Survival Lawrence Okiror, MBChB, Li Jiang, MBChB, Nicola.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Video-Assisted Thoracoscopic Surgery is More Favorable Than Thoracotomy for Resection of Clinical Stage I Non-Small Cell Lung Cancer Bryan A. Whitson,

Outcomes After Transhiatal and Transthoracic Esophagectomy for Cancer

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

William M. Whited, MD, Paul Henley, BS, Erin M

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer Giulio Maurizi, MD, Antonio D’Andrilli, MD, Anna Maria.

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer Hyun Jin Cho, MD, Sung Ryong Kim, MD, Hyeong Ryul Kim, MD,

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Phillip S. Naimo, BS, Matthew S

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Presentation transcript:

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB, James McShane, BS, Michael P. Poullis, BS (Hons), MBBS, MD, MIEEE, FRCS (CTh) The Annals of Thoracic Surgery Volume 95, Issue 1, Pages 276-284 (January 2013) DOI: 10.1016/j.athoracsur.2012.09.051 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier survival plot shows the stage-matched 5-year survival after resection for non-small cell lung cancer: stage IA, solid line; stage IB, dashed line; stage II, dotted line; and stage IIIA, dashed-dotted line. The Annals of Thoracic Surgery 2013 95, 276-284DOI: (10.1016/j.athoracsur.2012.09.051) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 (A) The number of symptoms patients reported at diagnosis. (B) Frequency of main presenting symptom at diagnosis. Symptoms relating to pie-chart segments are found in the corresponding colour co-ordinated legend to the right of the chart. The Annals of Thoracic Surgery 2013 95, 276-284DOI: (10.1016/j.athoracsur.2012.09.051) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Number of symptomatic (red bars) vs asymptomatic (blue bars) patients at diagnosis (p < 0.05). The Annals of Thoracic Surgery 2013 95, 276-284DOI: (10.1016/j.athoracsur.2012.09.051) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Kaplan-Meier survival plot for all symptomatic (green lines) and asymptomatic (blue lines) patients at diagnosis (p = 0.489). The Annals of Thoracic Surgery 2013 95, 276-284DOI: (10.1016/j.athoracsur.2012.09.051) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Kaplan-Meier survival curve for stage I disease in symptomatic (green lines) and asymptomatic (blue lines) patients (p = 0.55). The Annals of Thoracic Surgery 2013 95, 276-284DOI: (10.1016/j.athoracsur.2012.09.051) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 6 Kaplan-Meier survival curve for stage II disease in symptomatic (green lines) and asymptomatic (blue lines) patients (p = 0.81). The Annals of Thoracic Surgery 2013 95, 276-284DOI: (10.1016/j.athoracsur.2012.09.051) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 7 Kaplan-Meier survival curve for stage IIIa disease symptomatic (green lines) and asymptomatic (blue lines) patients (p = 0.61). The Annals of Thoracic Surgery 2013 95, 276-284DOI: (10.1016/j.athoracsur.2012.09.051) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions